Literature DB >> 1886623

Inflammatory bowel disease (2)

D K Podolsky1.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1886623     DOI： 10.1056/NEJM199110033251406

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  88 in total

Review 1.  Drug therapy of ulcerative colitis.

Authors:  B Crotty; D P Jewell
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

2.  Leukotriene C4 D4 antagonist markedly reduced inflammation in a rat model of inflammatory bowel disease.

Authors:  Y Hikasa; M Nishikawa; K Hori; K Furukawa; K Yamada; N Tanida; T Shimoyama
Journal:  Gastroenterol Jpn       Date:  1992-12

3.  The serum factor from patients with ulcerative colitis that induces T cell proliferation in the mouse thymus is interleukin-7.

Authors:  M Watanabe; N Watanabe; Y Iwao; H Ogata; T Kanai; Y Ueno; M Tsuchiya; H Ishii; S Aiso; S Habu; T Hibi
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

Review 4.  Nutritional modulation of the inflammatory response in inflammatory bowel disease--from the molecular to the integrative to the clinical.

Authors:  Gary E Wild; Laurie Drozdowski; Carmela Tartaglia; M Tom Clandinin; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

5.  Diagnostic difficulty arising from rectal recovery in ulcerative colitis.

Authors:  T S Levine; M Tzardi; S Mitchell; C Sowter; A B Price
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

6.  Serotonin activates dendritic cell function in the context of gut inflammation.

Authors:  Nan Li; Jean-Eric Ghia; Huaqing Wang; Jessica McClemens; Francine Cote; Youko Suehiro; Jacques Mallet; Waliul I Khan
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

7.  Maintenance of remission with infliximab in inflammatory bowel disease: efficacy and safety long-term follow-up.

Authors:  Renato Caviglia; Mentore Ribolsi; Marina Rizzi; Sara Emerenziani; Maria Laura Annunziata; Michele Cicala
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

8.  Dexamethasone 21-sulfate improves the therapeutic properties of dexamethasone against experimental rat colitis by specifically delivering the steroid to the large intestine.

Authors:  Inho Kim; Hyesik Kong; Younghyun Lee; Sungchae Hong; Jungoh Han; Sunhwa Jung; Yunjin Jung; Young Mi Kim
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

Review 9.  The paradoxical effects of vitamin D on type 1 mediated immunity.

Authors:  Margherita T Cantorna; Sanhong Yu; Danny Bruce
Journal:  Mol Aspects Med       Date:  2008-05-04

Review 10.  Pulmonary involvement and allergic disorders in inflammatory bowel disease.

Authors:  Nikolaos E Tzanakis; Ioanna G Tsiligianni; Nikolaos M Siafakas
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.